Bala

ICSR Management

Crafting a Well-Structured ICSR Narrative

Within this extensive pharmacovigilance blog, specifically focusing on Individual Case Safety Reports (ICSRs), we meticulously construct a model narrative, line by line, outlining the essential information to be incorporated. By engaging with this content, you’ll acquire valuable insights into narrative writing within the context of ICSR reporting.

Bala

Read

Exploring Adverse Events

Counterfeit Drugs: An Adverse Event

In this comprehensive article, we delve into the world of counterfeit medicines. We explore what they are, how they are classified as adverse events, and the considerations involved.

Bala

Read

Drug safety and pharmacovigilance

Understanding Civil Money Penalties

In this pharmacovigilance blog, we will delve into the details of civil penalties, addressing any uncertainties regarding the amount of penalties for late submissions or the provision of misleading data. Take a moment to read and gain clarity through this blog. Happy reading!

Bala

Read

Drug safety and pharmacovigilance

Validating Incident Country: Key in Case Processing

Welcome to our informative pharmacovigilance blog, where we explore the significance of the country of incidence in ICSR (Individual Case Safety Report) case processing and its potential impact on the outcome of the case. Join in our journey through the world of pharmacovigilance.

Bala

Read

MedDRA Series

The Vision and Mission of MedDRA

In this insightful blog post, you will delve deep into the intricate layers of MedDRA’s vision and mission, exploring its evolution over time, and its ambitious overarching goals. Ultimately ensuring public safety and enhancing the quality of healthcare services.

Bala

Read

Public Authorities and Safety

Adverse Event Reporting System (AERS) – An overview

Welcome to this insightful blog, where we delve into the purpose and benefits of AERS (Adverse Event Reporting System) and explore how it aids regulatory bodies in effectively addressing the potential harmful effects of drugs on the general population. Join us as we uncover the significance of AERS in ensuring drug safety and public health.

Bala

Read

Talk About Quality

Achieving Quality output: The Best Practices

In this informative pharmacovigilance blog, where we provide you with a wealth of knowledge on conducting quality checks in Individual Case Safety Report (ICSR) cases. Discover in-depth information, insights and responsibilities about the guidelines associated with performing these checks.

Bala

Read

Public Authorities and Safety

The Clock is Ticking: Significance of Regulatory Timelines

From this blog, where you systematically explore regulatory timelines based on case criteria determined by authorities. If you’re looking to navigate the complexities of regulatory timelines, you’ve come to the right place.

Bala

Read